Previous close | 161.33 |
Open | 161.33 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 161.33 - 161.33 |
52-week range | 111.91 - 161.33 |
Volume | |
Avg. volume | 47 |
Market cap | 38.528B |
Beta (5Y monthly) | 0.26 |
PE ratio (TTM) | 36.34 |
EPS (TTM) | 4.44 |
Earnings date | N/A |
Forward dividend & yield | 2.24 (1.39%) |
Ex-dividend date | 10 May 2024 |
1y target est | N/A |
WALTHAM, Mass., March 28, 2024--To help prepare nursing students for real-world practice, Wolters Kluwer Health today announces the launch of Lippincott Ready for NCLEX®, a complete test prep solution for the National Council Licensure Examination (NCLEX). The new product marks the organization’s entrance into nursing education testing, with a comprehensive learning solution designed to empower the next generation of nurses.
NEW YORK, March 28, 2024--Wolters Kluwer, a global leader in information, software, and services for professionals, today announces that its CCH® Tagetik expert solution has retained its leadership position for the seventh consecutive year in both the Global and DACH region issues of the prestigious BARC Score Financial Performance Management (FPM) Report.
Share Buyback Transaction Details March 21 – March 27, 2024 March 28, 2024 - Wolters Kluwer (Euronext: WKL), a global leading provider of expert solutions, insights and services for professionals, today reports that it has repurchased 156,678 of its own ordinary shares in the period from March 21, 2024, up to and including March 27, 2024, for €22.8 million and at an average share price of €145.57. These repurchases are part of the share buyback program announced on February 21, 2024, under which